Audit, monthly oversight, or governed MCP — pick the first buy
Antonio Chagoury, Founder & CEOAugust 25, 2026
The forcing function is already on the calendar. A customer security questionnaire asks how Copilot output is reviewed. Diligence wants a findings trail. A release train is shipping faster than senior review can keep up. The question is not “should we use AI coding tools.” You already are. The question is which engagement to buy first so the next reviewer sees evidence, not a process claim.
Most teams collapse three different products into one Slack thread: a point-in-time AI code audit, a monthly AI code oversight retainer, and a production governed MCP layer so agents can reach CRM, EHR, or ERP under auth. Those are not three names for the same work. Buying the wrong one wastes a quarter. Buying none of them is how a scanner-green repo still fails the questionnaire.
This is a decision guide. If you need the audit unpacked in depth — what it covers, how it differs from a pentest, how access works — use the existing AI code audit guide. What follows is when to start there, when to skip ahead to a retainer, and when the real blocker is agent access to systems of record rather than Copilot diffs.
What AI code oversight is
An AI code oversight engagement is a monthly retainer: senior engineers inspect AI-assisted diffs and agreed paths on your shipping rhythm — sprint, release train, or monthly batch — and deliver written findings you can show a buyer or auditor. It is not a chatbot. It is not a RAG wrapper. It is not “we will be your AI team.” Client code stays in your environment. Review is direct inspection by named senior engineers.
Oversight is the product after the snapshot. An audit answers “what is in the repo right now.” Oversight answers “does review quality keep up as Copilot, Cursor, and Claude Code keep merging.” If velocity already outpaced review, a one-shot report goes stale in two sprints. That is the forcing function for the retainer — not a preference for longer contracts.
The problem is not AI. It is review capacity.
Assistants accelerate merges. Senior review does not automatically accelerate with them. The failure mode is familiar: authorization edges that look correct, coupling your roadmap cannot afford, secrets and unvetted packages, PHI paths that policy documents but code does not enforce. Scanners catch some of it. They do not sign the questionnaire. They do not sit in the diligence room. They do not know your BAA.
A green CI badge is hygiene. A severity-ranked finding with a named engineer is evidence. If you cannot produce the second, you are not ready for the buyer who is about to look — regardless of how fast the team ships. The free AI Code Risk Checklist is the self-serve version of that gap. The paid path is audit, then oversight, unless the blocker is agents on production data.
Three products, three questionnaires
Keep the buyer question in the left column. The SKU follows from it.
| You need to answer | Buy first | What you get |
|---|---|---|
| What did AI already write into this repo, before diligence, a questionnaire, or an incident review? | AI Code Audit | Fixed-scope written findings in 5–10 business days after read-only access. Named engineer. Point in time. |
| We will keep shipping with Copilot, Cursor, or Claude Code. Who reviews the next cycle? | AI Code Oversight | Monthly senior pass on AI-assisted diffs. Cadence in writing. Findings each cycle, not a quarterly slide. |
| Agents need CRM, EHR, ERP, or internal APIs — and InfoSec will not approve paste-into-ChatGPT. | Governed MCP | Production Model Context Protocol servers: auth, least privilege, audit trail, in your environment. |
Tool-specific search still has a landing: Copilot & Cursor code audit. Prompt-built products that never had an engineering process start with vibe coding governance, not a Copilot-on-a-mature-repo audit. If the question is where source is hosted — GitHub vs Cursor Origin vs a mirror — that is platform governance, not oversight of diffs.
A 30-minute decision tree
- Is there a date? Fundraise, customer questionnaire, SOC 2 fieldwork, incident debrief. If yes, buy the audit first. You need a snapshot that can be attached to an email. Oversight does not replace that packet.
- Will the team keep merging AI-assisted code after that date? If yes, scope oversight in the same conversation. Do not wait for the report to go stale. Audit-then-retainer is the default expansion path.
- Is the blocker “the agent cannot touch the system of record”? That is MCP. Do not buy a code audit hoping it will magically authorize Claude against the EHR. Different questionnaire, different threat model. Read custom MCP servers for enterprise AI when that is the actual constraint.
- Healthcare / PHI? Same three SKUs, plus a BAA-aware boundary. Product delivery on clinical systems also goes through Maxiom Labs. Do not mix PHI-in-the-agent with Copilot-in-the-repo in one SOW unless both are scoped in writing.
If you cannot answer (1)–(3) in thirty minutes, you do not need a six-week discovery. You need a scoping call that ends in a written yes or no.
What good oversight looks like
A retainer that cannot produce artifacts is a slide deck with a monthly invoice. Demand:
- Cadence in writing — sprint, release-gated, or monthly batch — before the first cycle
- NDA, then read-only access; no third-party AI on client source
- Severity-ranked findings each cycle, plus a live walkthrough
- A named senior engineer, not a rotating ticket queue
- Optional separate scope if Maxiom implements critical fixes — do not bury build work inside “review”
If your InfoSec team will not grant read-only GitHub access, you do not have an oversight problem yet. You have an access-model problem. Fix that on the scoping call, not after kickoff.
Hire vs DIY
Do it internally when senior reviewers already have capacity, AI-assisted volume is small, and nobody is asking for an independent findings trail. Document the review bar anyway. The next questionnaire will.
Buy an audit when a date exists and you need a written baseline — or when leadership does not trust the last two quarters of “we review everything.” Independent is the point. Internal review of your own Copilot output is not what a buyer wants to hear.
Buy oversight when the audit (or your own scorecard) shows the gap is ongoing, not a one-time mess. Recurring merge volume without recurring senior judgment is how the next incident happens on a path nobody re-read.
Buy MCP when agents are the product surface and the system of record cannot be pasted into a consumer model. Pair it with audit or oversight if those same teams also ship Copilot-written application code. Two questionnaires. Two engagements. See also compliance engineering when the findings need to become controls in the product, not a PDF in a shared drive.
FAQ: audit vs oversight vs MCP
What is AI code oversight?
A monthly retainer in which senior engineers inspect AI-assisted code on your release cadence and deliver written findings. It is the recurring product after a point-in-time audit — not a chatbot or RAG subscription.
Should we start with an audit or with oversight?
Start with an AI code audit when you need a snapshot before a deadline. Start with oversight only if you already have a recent independent findings trail and the problem is keeping up, not establishing a baseline. Most new logos buy the audit first.
Is this a chatbot or “AI team” retainer?
No. Maxiom does not sell chatbot hours, RAG wrappers, or a bench that writes your product in a third-party model. Oversight is senior review of code your team already wrote with assistants. MCP is infrastructure so agents can call your systems under auth.
Can scanners or AI PR bots replace oversight?
No. They are useful hygiene. They do not judge architecture against your roadmap, map findings to HIPAA or SOC 2, or sign a diligence narrative. Use them in CI. Do not hand their output to a buyer as the review program.
What cadence should we pick?
Sprint-aligned if you already ship on two-week iterations. Release-gated if deploys are fewer and higher-stakes. Monthly batch if volume is bursty. Cadence is a scoping decision, written before access — not a vibe after the first invoice.
Does Maxiom run our code through third-party AI?
No. Client code stays in client environments. NDA first, read-only by default. That is true for audit, oversight, and MCP.
When is governed MCP the first buy?
When InfoSec is blocking agents on CRM, EHR, ERP, or internal APIs, and the risk is tool access and data class — not Copilot diffs. If both are true, buy both, in two scopes. Do not hide MCP inside an audit SOW.
We handle PHI. Does that change the first SKU?
The decision tree is the same. The access model is stricter. Healthcare product work and clinical systems go through Maxiom Labs. Say PHI on the scoping call so the SOW does not pretend a generic SaaS review is a BAA engagement.
Next step
If a date is on the calendar, request the audit. If you will still be merging AI-assisted code after that date, scope oversight in the same conversation. If the blocker is agents on a system of record, start with governed MCP. Download the AI Code Risk Checklist if you need a self-serve pass tonight. Thirty minutes on a scoping call is enough to pick one — or to hear that we are not the fit.
